// App-Quantinova.ai

S4022 2016 AHA : Urinary 11-Dehydro-Thromboxane B2: A Novel Thrombosis Risk Marker in LVAD Recipients

Researchers

Presenter

  • Kevin Bliden

Principal Investigators

  • Udaya Tantry

  • Sheila Phillips

  • Christopher McLeod

  • Mary Bradbury

  • Christopher O Connor

  • Paul Gurbel

Medical Centers

  • Inova Heart and Vascular Inst, Falls Church, VA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Creatinine

Drug/Treatment

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved